I thought this was worth sharing. From Dante on YM
Post# of 148158
(Total Views: 681)
Posted On: 12/16/2021 8:38:46 AM
I thought this was worth sharing. From Dante on YMB:
dante
"Apologizes to longs my hypothesis on the call was wrong. I’ve never seen a company do a market hours CC without significant market moving news especially in December (partner and buy out season).…. I have to stay 100% truthful to longs. I thought the call wasn’t needed and had little to no new information. Even the “new hires” they talked about that on previous calls. I think the biggest problem we have is “perception” there are biotechs in phase 1 with 2 indications for cancer their on nasdaq and stock prices are 15+ Dollars. Even the arena 100$ buy out from Pfizer. They have 2 drugs in phase 3……….all their pipeline combined doesn’t equal LERONLIMAB’S indications and market potential. We have a phase 3 trial that hit stat sig as well. They don’t.
The problem we face is when someone mentions Cydy they don’t think about this life saving molecule. The public perception is “oh that’s the company with all that noise and controversy” a lot of it forced and tactically put upon us by the dark powers that try to see us destroyed. But I believe the management can minimize this be more stealth coming into 2022.
First. Stop addressing “shorts” most are run by bots anyways that use a sentence generator algo with a timer to release comments at different times throughout the day. Second. If you want “shorts” to not bash data put out detailed PR’s that make sense and clarify everything to a TEE. I think it would also be great if every PR had a Column “Dr.Recknors data analysis” where he breaks the data down and gives his opinions. People want to hear what he has to say. It should be him in every PR. Then no one will be able to “bash the data”
third. People are being desensitized to NEWS. Why release the 5 patients of NASH data just release the whole study when it’s ready with a top line report for MAX impact. If data needs to be explained please put dr. Recknor on a proactive so he can do it. In future CC’s I think it would be nice we hear from the cydy biomarkers lab teammates. 2022 is the biggest year of the companies history. There needs to be changes on the public perception of the company a lot of it is out of the companies hands but they can also help themselves minimize it.
Nadar you should put this Quote on your office wall.
“Let your plans be dark and impenetrable as night, and when you move, fall like a thunderbolt.”
Sun Tzu, The Art of War
GODSPEED."
dante
"Apologizes to longs my hypothesis on the call was wrong. I’ve never seen a company do a market hours CC without significant market moving news especially in December (partner and buy out season).…. I have to stay 100% truthful to longs. I thought the call wasn’t needed and had little to no new information. Even the “new hires” they talked about that on previous calls. I think the biggest problem we have is “perception” there are biotechs in phase 1 with 2 indications for cancer their on nasdaq and stock prices are 15+ Dollars. Even the arena 100$ buy out from Pfizer. They have 2 drugs in phase 3……….all their pipeline combined doesn’t equal LERONLIMAB’S indications and market potential. We have a phase 3 trial that hit stat sig as well. They don’t.
The problem we face is when someone mentions Cydy they don’t think about this life saving molecule. The public perception is “oh that’s the company with all that noise and controversy” a lot of it forced and tactically put upon us by the dark powers that try to see us destroyed. But I believe the management can minimize this be more stealth coming into 2022.
First. Stop addressing “shorts” most are run by bots anyways that use a sentence generator algo with a timer to release comments at different times throughout the day. Second. If you want “shorts” to not bash data put out detailed PR’s that make sense and clarify everything to a TEE. I think it would also be great if every PR had a Column “Dr.Recknors data analysis” where he breaks the data down and gives his opinions. People want to hear what he has to say. It should be him in every PR. Then no one will be able to “bash the data”
third. People are being desensitized to NEWS. Why release the 5 patients of NASH data just release the whole study when it’s ready with a top line report for MAX impact. If data needs to be explained please put dr. Recknor on a proactive so he can do it. In future CC’s I think it would be nice we hear from the cydy biomarkers lab teammates. 2022 is the biggest year of the companies history. There needs to be changes on the public perception of the company a lot of it is out of the companies hands but they can also help themselves minimize it.
Nadar you should put this Quote on your office wall.
“Let your plans be dark and impenetrable as night, and when you move, fall like a thunderbolt.”
Sun Tzu, The Art of War
GODSPEED."
(14)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼